West Virginia Clinical and Translational Science Institute
Background: Single-tablet regimens are preferred prescription choices for HIV treatment, but there are limited outcomes data comparing single-tablet regimens to multiple-tablet regimens. Methods: We retrospectively assessed treatment-naïve patients at a single urban HIV clinic in the United States for viral load suppression at 6 and 12months after initiating either single-tablet or multiple-tablet regimens. Multivariate regression was performed to obtain relative risks and adjust for potential confounders. Results: Of 218 patients, 47% were on single-tablet regimens and 53% on multiple-tablet regimens; 77% of single-tablet regimen patients had undetectable viral load at 6months compared to 61% of multiple-tablet regimen patients (p=0.012). At 12months, 82% on single-tablet regimens and 66% on multiple-tablet regimens (p=0.019) had undetectable viral load. Relative risk of any detectable viral load was 1.6 (95% confidence interval: 1.1–2.5) for patients on multiple-tablet regimens compared to single-tablet regimens at 6months, and 2.2 (95% confidence interval: 1.2–4.0) at 12months. Conclusion: Single-tablet regimens may provide better virologic control than multiple-tablet regimens in urban HIV-infected persons.
Digital Commons Citation
Kapadia, Shashi N.; Grant, Robert R.; German, Susan B.; Singh, Baljinder; Davidow, Amy L.; Swaminathan, Shobha; and Hodder, Sally, "HIV virologic response better with single-tablet once daily regimens compared to multiple-tablet daily regimens" (2018). Clinical and Translational Science Institute. 950.
Kapadia SN, Grant RR, German SB, et al. HIV virologic response better with single-tablet once daily regimens compared to multiple-tablet daily regimens. SAGE Open Medicine. 2018;6:205031211881691. doi:10.1177/2050312118816919